Credit Suisse’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-48,981
| Closed | -$6K | – | 3486 |
|
|
2018
Q4 | $6K | Sell |
48,981
-156,024
| -76% | -$19.1K | ﹤0.01% | 3316 |
|
|
2018
Q3 | $348K | Sell |
205,005
-63,998
| -24% | -$109K | ﹤0.01% | 2991 |
|
|
2018
Q2 | $468K | Sell |
269,003
-27,441
| -9% | -$47.7K | ﹤0.01% | 3003 |
|
|
2018
Q1 | $543K | Buy |
296,444
+4,046
| +1% | +$7.41K | ﹤0.01% | 2911 |
|
|
2017
Q4 | $652K | Sell |
292,398
-53,880
| -16% | -$120K | ﹤0.01% | 2800 |
|
|
2017
Q3 | $1M | Sell |
346,278
-56,616
| -14% | -$164K | ﹤0.01% | 2644 |
|
|
2017
Q2 | $1.79M | Sell |
402,894
-325,458
| -45% | -$1.45M | ﹤0.01% | 1964 |
|
|
2017
Q1 | $3.4M | Buy |
728,352
+487,434
| +202% | +$2.27M | ﹤0.01% | 1655 |
|
|
2016
Q4 | $1.47M | Sell |
240,918
-7,109
| -3% | -$43.3K | ﹤0.01% | 2376 |
|
|
2016
Q3 | $1.37M | Buy |
248,027
+52,887
| +27% | +$291K | ﹤0.01% | 2386 |
|
|
2016
Q2 | $742K | Sell |
195,140
-87,125
| -31% | -$331K | ﹤0.01% | 2880 |
|
|
2016
Q1 | $780K | Buy |
282,265
+56,972
| +25% | +$157K | ﹤0.01% | 2634 |
|
|
2015
Q4 | $1.28M | Buy |
225,293
+39,038
| +21% | +$221K | ﹤0.01% | 2424 |
|
|
2015
Q3 | $988K | Sell |
186,255
-13,661
| -7% | -$72.5K | ﹤0.01% | 2653 |
|
|
2015
Q2 | $1.66M | Buy |
199,916
+107,541
| +116% | +$893K | ﹤0.01% | 2481 |
|
|
2015
Q1 | $427K | Sell |
92,375
-39,684
| -30% | -$183K | ﹤0.01% | 3388 |
|
|
2014
Q4 | $403K | Sell |
132,059
-1,847
| -1% | -$5.64K | ﹤0.01% | 3497 |
|
|
2014
Q3 | $373K | Sell |
133,906
-44,480
| -25% | -$124K | ﹤0.01% | 3433 |
|
|
2014
Q2 | $726K | Buy |
178,386
+48,193
| +37% | +$196K | ﹤0.01% | 3147 |
|
|
2014
Q1 | $691K | Buy |
130,193
+10,055
| +8% | +$53.4K | ﹤0.01% | 3104 |
|
|
2013
Q4 | $667K | Buy |
120,138
+28,308
| +31% | +$157K | ﹤0.01% | 3173 |
|
|
2013
Q3 | $414K | Sell |
91,830
-94,094
| -51% | -$424K | ﹤0.01% | 3185 |
|
|
2013
Q2 | $792K | Buy |
+185,924
| New | +$792K | ﹤0.01% | 2610 |
|